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Abstract 
Background: For most low- and middle-income countries, mental health remains a 
neglected area, despite the recognized burden associated with neuropsychiatric 
conditions and the inextricable link to other public health priorities. 
Aims: To describe the results of a free out-patient mental health program delivered by 
non-specialist health workers in Makeni (Sierra Leone) between July 2008 and May 
2012.  
Methods: A nurse and two counselors completed an eight-week training course focused 
on the identification and management of seven priority conditions: psychosis, bipolar 
disorder, depression, mental disorders due to medical conditions, developmental and 
behavioral disorders, alcohol and drug use disorders, and dementia. The WHO 
recommendations on basic mental health care packages were followed to establish 
treatment for each condition.  
Results: Five hundred and forty-nine patients were assessed and diagnosed as suffering 
from psychotic disorders (n=295, 53.7%), manic episodes (n=69, 12.5%), depressive 
episodes (n=53, 9.6%), drug use disorders (n=182, 33.1%), dementia (n=30, 5.4%), 
mental disorders due to medical conditions (n=39, 7.1%), and developmental disorders 
(n=46, 8.3%). Four hundred and seventeen patients received pharmacological therapy 
and 70.7% of them were rated as much or very much improved. 93.4% of those who 
could not be offered medication dropped out of the program after the first visit.  
Conclusions: The identification and treatment of mental disorders must be considered 
an urgent public health priority in low- and middle-income countries. Trained primary 
health workers can deliver safe and effective treatment for mental disorders, this being a 
feasible alternative to ease the scarcity of mental health specialists in developing 
countries.  
Declaration of interest: none. 
Introduction 
Mental disorders are an important cause of long-term disability and dependency, with 
the 2005 WHO report attributing 31.7% of all years lived-with-disability to 
neuropsychiatric conditions
1
. The five major contributors to this total are unipolar 
depression (11.8%), alcohol-use disorder (3.3%), schizophrenia (2.8%), bipolar 
depression (2.4%), and dementia (1.6%)
2
. This significant burden of mental, 
neurological, and substance use disorders affects not only more developed countries but 
also those which are poorer and less well resourced. However, mental health remains a 
low priority in most low- and middle-income countries (LMIC), which tend to prioritize 
the control and eradication of infectious diseases, as well as reproductive, maternal, and 
child health
3
. Investment in mental health is often perceived in these countries as having 
an unaffordable opportunity cost. As a result, there is an astonishingly large treatment 
gap for people with neuropsychiatric disorders in LMIC
4
. While at least two-thirds of 
all persons with mental illnesses go untreated worldwide, the figure for low-resource 
countries exceeds 90%
5
. 
There is also a conspicuous lack of published literature evaluating the implementation 
of mental health care programs in low-income countries
6
. Fewer than 1% of identified 
trials worldwide that aimed to treat or prevent schizophrenia, depression, developmental 
disabilities, or alcohol-use disorder were conducted in low-income countries, and of 
these about two-thirds come from China
7
. In the case of sub-Saharan Africa the vast 
majority of published data from mental health research (nearly 70%) is focused on 
South Africa
8,9
, an emerging country that is not representative of the region as a whole. 
Sierra Leone, in the sub-Saharan area, occupies one of the lowest positions in the 
Human Development Index drawn up in 2008
10
, it being ranked 128
th
 among 135 
countries for which a Human Poverty Index was calculated
10
. The proportion of its 
population below the poverty line of 1.25 USD per day is estimated at 47.7%. The 
country has recently emerged from a brutal, decade-long civil war during which 
civilians were victims of widespread violence, including amputation of body parts, rape, 
and forced labor
11
. After this devastating conflict, the health system, like all public 
systems, was in tatters. Nevertheless, the country has managed to implement a free 
healthcare plan for pregnant women, breastfeeding mothers, and children younger than 
five years, that has been proposed as an example for LMIC
12
. As countries such as 
Sierra Leone continue to rebuild after conflicts, the need to develop services for all from 
the ground up may offer a unique window of opportunity for the inclusion of persons 
suffering from mental disorders into the health system. 
Locally-conducted research is crucial to provide more direct evidence regarding cost-
effective interventions that may help low-income countries use their limited financial 
and human resources for mental health as effectively as possible
13
. This paper describes 
the results of a free out-patient mental health program that was run in Makeni (Sierra 
Leone) between July 2008 and May 2012. The program was delivered by trained non-
specialist health workers integrated into the existing healthcare system. 
 
MATERIAL AND METHODS 
Intervention site 
At present there is not a single psychiatrist in Sierra Leone, and only occasionally is 
there input from foreign professionals via NGOs. The country has only one facility for 
treating mental health patients on a long-term basis using Western medicine, the Kissy 
Mental Hospital in Freetown, the capital of Sierra Leone. Makeni, located 
approximately 137 km east of Freetown, is the fifth largest city in Sierra Leone and is 
the economic center of the Northern Province. It has a current estimated population of 
109,112 inhabitants and is the capital of the Bombali District, whose estimated 
population is 439,319. 
The Holy Spirit Hospital is linked to the University of Makeni, and both form part of 
the Catholic Diocese of Makeni. The hospital has a 70-bed admission ward and treats 
300 in-patients and 1200 out-patients per month. It has three general doctors and 50 
nurses and support staff. The mental health program was initiated in July 2008 as a free 
out-patient program open to patients from Makeni and its surrounding district. The 
program staff comprised a nurse and two counselors, who underwent an eight-week 
training course, run by a volunteer psychiatrist, focusing on the identification and 
management of mental disorders. Seven priority conditions were considered: 
depression, psychosis, bipolar disorder, mental disorders due to medical conditions 
(mainly epilepsy, stroke and brain injury), developmental and behavioral disorders in 
children and adolescents, alcohol and drug use disorders, and dementia. These areas 
were chosen because they represent a considerable burden in terms of mortality, 
morbidity, or disability, have high economic costs, and are often associated with 
violations of human rights
14,15
. Patel et al.
14
, as well as the Mental Health Gap Action 
Program (mhGAP) published by the WHO in 2010, recommend the use of similar 
global diagnostic classes in order to increase the validity of the diagnostic process, since 
non-specialist health workers generally find it easier to differentiate between these 
major classes of disorders (e.g., schizophrenic disorders versus affective disorders) than 
within classes of disorders (e.g., schizophrenic disorders versus schizoaffective 
disorders); the latter would, of course, allow the use of more complicated diagnostic 
classifications such as DSM-IV-TR or ICD-10.  
The WHO recommendations on basic mental health care packages were followed in 
order to establish treatment for each diagnostic condition
16
. This means outpatient-based 
treatment of schizophrenia and bipolar disorder with first-generation antipsychotic 
drugs and adjuvant psychosocial treatment, and proactive care of depression with 
generic selective serotonin reuptake inhibitors or tricyclic antidepressants and 
maintenance treatment of recurrent episodes. Mood stabilizing drugs such as lithium or 
valproate were not administered for bipolar disorders due to the lack of laboratory 
facilities for monitoring these drugs. Anticholinergic agents were not routinely 
prescribed but were given to those patients who developed extrapyramidal side effects. 
Patients were asked to attend the program accompanied by a family member, who was 
responsible for medication administration. Pharmacological treatment was provided 
solely by the nurse for an initial period of three days, after which the patient was asked 
to re-contact the program. If no severe adverse effect was detected, medication was 
provided for a maximum period of one month. All patients were asked to contact the 
program for follow-up assessment at least monthly. Brief psychological interventions, 
based on motivational techniques for alcohol and other drug use disorders, as well as 
psycho-education about mental illness, promotion of treatment adherence, and support 
to families and caregivers for the other conditions, were offered by the two counselors.  
The cost of the program was borne by 1) CAFOD (the Overseas Development and 
Relief Agency of the Catholic Church in England and Wales), which provided 
medication and covered the salary of the two counselors, and 2) the Holy Spirit 
Hospital/University of Makeni, which paid the nurse’s salary and provided a hospital 
annex area from which the program could be run. 
 
Data collection 
A specific form was developed to facilitate the assessment of patients (see 
Supplementary material). This covered socio-demographic information (age, gender, 
completed years of education, marital status, and employment), service utilization 
(previous contact with primary healthcare providers, traditional healers, and hospital 
services; medication use), and clinical information (alcohol and drug consumption, 
family psychiatric history, age at onset of psychiatric symptoms, and 
psychopathological assessment). All patients were initially assessed by the nurse and 
then independently reassessed by one of the counselors. Any differences in diagnostic 
opinion were discussed by the three members of the program team until a consensus 
was reached. 
Clinical changes were evaluated with the Clinical Global Impression — Improvement 
Scale (CGI-I), a 7-point scale that assesses how much the patient’s illness has improved 
or worsened relative to baseline. The patient’s status is rated as 1, very much improved; 
2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; 6, much 
worse; or 7, very much worse. 
Direct supervision on diagnoses and treatment procedures was provided for four weeks 
a year by different volunteer psychiatrists. All case records obtained during the previous 
year were examined during this supervision period in order to ensure optimal data 
collection, as well as to supervise the establishment of diagnoses. Informed consent was 
not available due to the characteristics of the environment, but the Institutional Review 
Board of the Adler School of Professional Psychology evaluated the project and did 
approve the analysis of data and presentation of results. All analyses were conducted in 
compliance with the principles set out in the Declaration of Helsinki (2008). 
 
Data analysis 
A database was built between July 2011 and May 2012 reviewing all available records. 
Descriptive statistics were applied to the socio-demographic and clinical characteristics 
of the sample. Gender differences and differences between diagnostic conditions were 
explored using χ² tests for categorical variables and independent samples t tests for 
continuous variables. These analyses were performed with SPSS v.19 (SPSS Inc., 
Chicago, IL) and significance thresholds were set at p<0.05, two-tailed. 
 
RESULTS 
Five hundred and forty-nine patients (327 males and 227 females) were assessed 
between July 2008 and May 2012 (see Figure 1). Men were significantly younger, 
tended to be single, reported a higher mean educational level, and were more likely to 
have a history of nicotine, alcohol, or cannabis abuse/dependence. Agitation and 
hallucinations were more common among men than women, whereas the latter reported 
more affective symptoms (from both the depressive and manic poles), loss of appetite, 
and a positive family psychiatric history (see Table 1).   
 
Insert Table 1 
 
The main psychiatric symptoms reported were agitation (76.8%); disorganized behavior 
(74.4%); insomnia (70.8%); heteroaggressive behavior (69.2%); hallucinations (52%); 
delusions (38.2%); loss of appetite (25%); depressive mood (15.8%), which included 
low mood, hopelessness, helplessness, worthlessness, loss of energy, and loss of interest 
in pleasurable activities; manic mood (12.5%), including elevated or irritable mood, 
expanded self-esteem, pressured speech, reduced need of sleep, increased distractibility, 
racing thoughts, and hyperactivity; and cognitive dysfunctions (10.0%), including 
disorientation, memory loss, difficulties with judgment, reasoning and understanding, 
and impaired organizational and language skills. Self-aggressive behavior, including 
suicide attempts and self-injurious behavior, was present in ten patients (1.8%).  
The main psychiatric diagnoses were psychotic disorders (n=295, 53.7%), manic 
episodes (n=69, 12.5%), depressive episodes (n=53, 9.6%), substance use disorders 
(n=182, 33.1%), dementia (n=30, 5.4%), mental disorders due to medical conditions 
(n=39, 7.1%), and developmental disorders (n=46, 8.3%). Although not included in the 
seven priority clinical conditions, 12 patients received a diagnosis of an anxiety disorder 
(post-traumatic stress disorder (PTSD) n=9, panic disorder n=2, obsessive-compulsive 
disorder (OCD) n=1). Socio-demographic and clinical differences between diagnoses 
are described in Table 2. While psychotic and substance use disorders were significantly 
more common among men, women presented significantly higher rates of affective 
episodes (manic and depressive) and dementia. 
 
Insert Table 2 
 
Pharmacological treatment was recommended in accordance with WHO criteria and, 
when available, was provided free to all patients (see Table 3 for specific drug 
prescriptions). Four hundred and seventeen patients received pharmacological therapy, 
while in 123 cases medication was prescribed but not available because of a run-off 
medication period in the program. In nine cases, pharmacological treatment was not 
considered necessary and some kind of counseling was implemented. Patients receiving 
pharmacological treatment attended the program for 6.0 ± 8.2 months (range, 0 to 42), 
while for those who were not offered medication the mean period of adherence to the 
program was 0.·1 ± 0.8 months (t=-8.1; p<0.001). Seventy of the patients receiving 
pharmacological treatment (16.7%) dropped out of the program after the first visit, 
while the corresponding figure for those who could not be offered medication was 115 
of 123 (93.4%) (Χ2=245.04, p<0.001). Two hundred and ninety-five of the patients 
receiving medication (70.7%) were rated as much or very much improved, whereas no 
patients achieved these ratings in the group not receiving medication. 
 
Insert Table 3 
 
Three hundred and eighty-nine patients (70.8%) reported having visited a traditional 
healer before contacting the mental health program. The percentage was significantly 
higher among women (77.1% vs. 66.5% in men) (Χ2=8.2, p<0.01). Regarding referral 
networks, 124 patients were referred to the mental health program by their family doctor 
(22.7%), while the remainder asked for help under their own initiative after having 
heard about the mental health program through other members of their communities. 
 
DISCUSSION 
This is the first description of the results of a mental health program designed and 
implemented in one of the world’s poorest countries, Sierra Leone, where not a single 
psychiatrist is available. Our results add to the emerging body of evidence showing that 
trained primary health workers can deliver safe and effective treatment for mental 
disorders by using low-cost pharmacological strategies and brief psychological 
interventions within a functioning primary healthcare system
17-20
. 
Most of the patients who were seen by the program presented severe mental disorders 
(psychotic disorders, manic episodes, severe depressive episodes), with the main reason 
for attending being behavioral disturbances (such as psychomotor agitation, 
heteroaggressive or disorganized behavior) that were having a significant impact on 
their environment. This is consistent with a previous report by Gesler and Nahim
21
 
concerning 407 patients treated at the Kissy Mental Hospital in Freetown. These authors 
found that 79.5% of in-patients and 62.8% of out-patients were diagnosed as psychotic, 
suggesting that in African cultures it is only individuals with severe and disruptive 
forms of mental disorders who seek treatment based on Western medicine. Anxiety 
disorders, which together with depressive disorders are the most commonly observed 
psychiatric condition
22
, were highly under-represented in our sample. In the future it 
would therefore be necessary to design programs that are able to detect and offer 
treatment to people with mental disorders that are not accompanied by severe behavioral 
disturbances, but which nonetheless produce significant distress and functional 
impairment in the patient
23
.  
Our results also highlight the fact that when patients with severe mental disorders are 
not offered medication there is a high risk that they will drop out of psychiatric care. By 
contrast, when some treatment is provided, help-seeking behavior is strengthened and 
this results in a greater demand for services
9
. Consequently, an adequate supply of 
psychotropic medication at primary healthcare level is an essential first step in the 
process of decentralization and the reintegration into society of users with severe mental 
disorders
9
. To this end, campaigns are required to raise awareness among donor 
agencies and policy makers in LMIC of the need for a sufficient and constant supply of 
psychotropic medication. The WHO Mental Health Gap Action Program (mhGAP) 
estimated the cost of the basic mental health care package for the seven most prevalent 
neuropsychiatric conditions to be US$ 3-4 per head of population per year in sub-
Saharan Africa
15
. Treatments for common mental disorders are about as cost-effective 
as antiretroviral treatments for HIV/AIDS, secondary prevention of hypertension, or 
glycemic control for diabetes
24
, and that is before taking into account the other 
economic benefits of mental health care such as reductions in inappropriate use of 
health care, absence from work due to sickness, and premature mortality, which could 
even outweigh the investment costs
25
. Furthermore, non-economic criteria, such as 
equitable access to health care, human rights protection, and poverty reduction might be 
at least as important within the broader process of setting priorities in mental health
26
. 
A substantial number of our patients, especially women, sought help from traditional 
healers before contacting our Western mental health program. These findings are 
consistent with previous data from Sierra Leone reported by Gesler and Nahim
21
, who 
found that 35.5% of in-patients and 65.2% of out-patients attending the Kissy Mental 
Hospital had previously contacted a traditional healer. Given the enormous shortage of 
skilled mental health human resources in Africa and the great inequities in their 
distribution, some authors have argued that traditional healers might play a role in the 
mental health care system alongside biomedical providers, although no consensus has 
been reached on this issue
27,28
. 
Our data should be interpreted in the light of several limitations. Firstly, Sierra Leone 
might not be representative of other low- and middle-income countries in other areas of 
the world. Therefore, more locally conducted research is needed in order to build 
knowledge about countries that, for example, have been exposed not to armed conflicts 
but to other poverty-maintaining factors. Secondly, patient clinical outcomes were 
evaluated solely by means of the CGI-Improvement Scale, and no global outcome data 
were available. In this regard, determining the real efficacy of the program would 
require more detailed information about patients’ ability to reintegrate within their 
family, work, and social contexts. Thirdly, there is a need for objective measures of the 
quality and quantity of supervision required to enable adequate delivery of mental 
health care by primary care workers. Establishing these measures would require more 
complex experimental interventions than the present observational design. Nonetheless, 
this is a key issue that needs to be addressed, not only for determining the validity and 
true applicability of primary care worker-led mental health programs, but also for 
clarifying the role to be played by specialist staff in these programs.  
The ratio of burden to available resources for mental health care in LMIC is extremely 
inequitable, perhaps one of the worst among all major health domains
5
. However, since 
mental disorders are so inextricably linked to other public health priorities
29
 (such as 
HIV/AIDS, maternal and child health, and diabetes) it is increasingly clear that there 
can be “no health without mental health”30. Effective, locally feasible, and affordable 
treatments for mental disorders do exist in developing countries
7
, but in order to take 
these further, common mental disorders need to be considered alongside other diseases 
associated with poverty so as to attract attention from health policy-makers and donors. 
However, this is not just an economic question. Government commitment on the need 
for a mental health policy and legislation, building mental health literacy, and 
implementing strategies for combating stigma and discrimination for the whole 
population are also critically important
9
. Given the scarcity of mental health specialists, 
one option for developing countries might be to decentralize and integrate mental health 
care into routine primary healthcare programs that are built around collaboration 
between non-specialist and specialist health workers. However, more studies are needed 
on the benefits, the human resources required, and the costs of such interventions, since 
current competing priorities and budgetary constraints force resources to be targeted at 
cost-effective care and prevention strategies for which there is credible evidence of 
effectiveness. 
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Figure 1. Number of patients assessed by the mental health program between July 2008 
and May 2012. 
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Table 1. Sociodemographic and clinical data of the 549 patients assessed at the mental 
health programme and comparison between genders. 
 
 Total 
(n =549) 
Male  
(n =327) 
Female 
(n =222) 
Comparison  among  genders 
 Mean, ± 
SD (range) 
Mean, ± SD 
(range) 
Mean, ± SD 
(range) 
t p 95% Confident 
Interval 
Age (years) 31.3 ± 16.1 
(3-90) 
28.1 ± 13.6 
(3-90) 
36.0 ± 18.4 
(4-81) 
-5.7 <0.001 -10.5- -5.1 
Age at onset  of mental 
disorder (years) 
27.2 ± 16.4 
(1-89) 
24.3 ± 14.2 
(1-89) 
31.5 ± 18.4 
(1-81)  
-5.0 <0.001 -10.0- -4.4 
Alive children 0.9 ± 1.6 
(0-7) 
0.2 ± 0.5 
(0-7) 
1.8 ± 2.0 
(0-7) 
-5.7 <0.001 -.21 – -1.0 
Treatment duration 
(months) 
4.6 ± 7.6 
(0-42) 
4.3 ± 6.9 
(0-42) 
5.0 ± 8.5 
(0-42) 
-1.0 0.2 -2.0 – 0.6 
    Χ2 p  
Marital status 
(single, n, %) 
284 
(51.7%) 
210  
(64.2%) 
74  
(33.3%) 
35.6 <0.001  
Education (n, %) 
- None 
- Primary 
- Secondary 
- University 
 
79 (14.3%) 
145 (26.4%) 
298 (54.2%) 
21 (3.8%) 
 
21 (6.4%) 
87 (26.6%) 
203 (62.0%) 
12 (3.6%) 
 
58 (26.1%) 
58 (26.1%) 
95 (42.7%) 
9 (4.0 %) 
44.7 <0.001  
Drugs 
abuse/dependence 
      
Nicotine  (n, %) 114 (20.7%) 95 (29.0%)  19 (8.5%) 35.6 <0.001  
Alcohol (n, %) 89 (16.2%) 75 (22.9%) 14 (6.3%) 28.4 <0.001  
Cannabis (n, %) 158 (28.7%) 147 (44.9%) 11 (4.9%) 106.4 <0.001  
Cocaine (n, %) 8 (1.4 %) 7 (2.1%) 1 (0.4%) 3.2 0.1  
Heroine (n, %) 1 (0.1%) 1 (0.3%) 0 (0%) 1.2 0.5  
Other drugs (n, %) 19 (3.4%) 17 (5.1%) 2 (0.9%) 7.5 0.02  
Family psychiatric 
history (n, %) 
127 (23.1%) 45 (13.7%) 82 (36.9%) 8.7 0.01  
Somatic illnesses       
Cerebral malaria (n, %) 7 (1.2%) 4 (1.2%) 3 (1.3%) 1.9 0.3  
Head injury (n, %) 26 (4.7%) 15 (4.6%) 11 (4.9%) 2.6 0.2  
Epilepsy (n, %) 25 (4.5%) 14 (4.2%) 11 (4.9%) 3.0 0.2  
Psychiatric 
simptoms 
      
Agitation (n, %) 422 (76.8%) 261 (79.8%) 161 (72.5%) 4.6 0.03  
Heteroagressive 
behavior (n, %) 
380 (69.2%) 248 (75.8%) 132 (59.4%) 16.6 <0.001  
Delusions (n, %) 210 (38.2%) 136 (41.5%) 74 (33.3%) 4.8 0.08  
Hallucinations (n, 
%) 
286 (52.0%) 192 (5.7%) 94 (42.3%) 14.8 <0.001  
Disorganized 
behavior (n, %) 
409 (74.4%) 252 (77.0%) 157 (70.7%) 3.3 0.06  
Self-aggresive 
behavior (n, %) 
10 (1.8%) 7 (2.1%) 3 (1.3%) 0.4 0.4  
Sleep disturbances 
   Insomnia 
   Reduced need of 
sleep 
 
389 (70.8%) 
33 (6.0%) 
 
234 (71.5%) 
13 (3.9%) 
 
155 (69.8%) 
20 (9.0%) 
5.9 0.05  
Reduced appetite 140 (25.5%) 67 (20.4%) 73 (32.8%) 10.9 0.004  
Depressive Mood 
(n, %) 
87 (15.8%) 38 (11.6%) 49 (22.0%) 12.6 0.002  
Manic mood (n,%) 69 (12.5%) 32 (9.7%) 37 (16.6%) 6.1 0.04  
Cognitive 
difficulties (n, %) 
55 (10.0%) 30 (9.1%) 25 (11.2%) 0.5 0.4  
 
Table 2. Diagnoses established in the 549 patients assessed at the mental health programme. 
 
 Psychotic 
disorders 
Manic 
episodes  
Depressive 
episodes 
Dementia Mental 
disorders due 
to medical 
conditions 
Developmental 
and behavioral 
disorders in 
children 
Substance 
use disorders 
PTSD Anxiety 
disorders 
other than 
PTSD 
Cases (n)* 295 69 53 30 39 46 182 9 3 
Gender 
(male/female, X
2
, 
p) 
205/90 
X
2
= 8.4 
P= 0.004 
31/38 
X
2
= 7.0 
P= 0.008 
20/33 
X
2
= 11.6 
P= 0.001 
11/19 
X
2
= 6.9 
P= 0.008 
24/15 
X
2
= 0.2 
P= 0.6 
26/20 
X
2
= 0.1 
P= 0.6 
160/22 
X
2
= 17.1 
P <0.001 
7/2 
X
2
= 1.2 
P= 0.02 
0/3 
X
2
= 4.4 
P= 0.03 
Age (years, mean ± 
SD) 
27.5 ± 8.9  
 
32.5 ± 12.6 
 
42.8 ± 13.8 
 
73.0 ± 8.3 
 
34.4 ± 15.3  11.0 ± 5.8 
 
28.6± 9.7  27.7 ± 9.2 37.0 ± 15.1 
Age at onset (years, 
mean ± SD) 
23.7 ± 7.1 
 
28.4 ± 11.8  39.0 ± 13.5  70.0 ± 8.4 29.3±  16.7 2.5 ± 2.1  
 
24.5 ± 8.8 20.5 ± 6.4 18.3 ± 7.0 
Treatment duration 
(months, mean, ± 
SD) 
5.3 ± 8.1 6.1 ± 8.5  5.0 ± 8.2 1.5 ± 2.9 3.8 ± 7.1 1.4 ± 2.8 5.2 ± 8.0 1.4 ± 1.5 0.3 ± 0.5 
Family psychiatric 
history (n, %)** 
52 (26.1%) 22 (52.3%) 
 
 
12 (37.5%) 6 (30%) 0 (0%) 3 (11.5%) 26 (21.6%) 0 (0%) 0 (0%) 
PTSD: post-traumatic stress disorder 
 
* Total cases > 549 patients, since SUDs (Substance use disorders) could be diagnosed as a comorbid condition to other psychiatric disorders. 
** Percentage of family psychiatric history was calculated for those patients with available information (n = 339 patients). 
Table 3. Pharmacological treatment implemented in the mental health programme.  
 
 Total 
(n=549) 
Male 
(n =327) 
Female  
(n =222) 
Comparison 
 
among genders 
 Mean, ± 
SD (range) 
Mean, ± 
SD 
(range) 
Mean, ± 
SD 
(range) 
t p 95% 
Confident 
Interval 
Treatment duration 
(months) 
4.6 ± 7.6 
(0-42) 
4.3 ± 6.9 
(0-42) 
5.0 ± 8.5 
(0-42) 
-1.0 0.·2 -2.0 – 0.6 
 n,% n,% n,% Χ2 p  
Psychopharmacological 
treatment* 
417 
(75.9 %) 
245 
(74.9%) 
172 
(77.4%) 
0.3 0.5  
Chlopromazine 315 
(57.3%) 
184 
(56.2%) 
131 
(59.0%) 
0.4 0.5  
Flufenazine 167 
(30.4%) 
109 
(33.3%) 
58 
(26.1%) 
3.2 0.07  
Haloperidol  11 
(2.0%) 
7 
(2.1%) 
4 
(1.8%) 
0.07 0.7  
Benzhexol 106 
(19.3%) 
75 
(22.9%) 
31 
(13.9%) 
7.0 0.008  
Amitryptiline  41 
(7.4%) 
17 
(5.1%) 
24 
(10.8%) 
5.4 0.01  
Traditional healer 389 
(70.8%) 
217 
(66.5%) 
172 
(77.1%) 
9.0 0.01  
Drop-out after the first 
visit 
184 
(33.5%) 
109 
(33.3%) 
75 
(34.2%) 
0.04 0.8  
Rated as much or very 
much improved 
(CGI=1-2) 
295 
(53.7%) 
180 
(55.0%) 
115 
(51.8%) 
1.9 0.3  
 
*Patients could receive more than one pharmacological treatment. 
 
 
